Compare Quest Diagnostics Inc (DGX) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs GoPro Inc — how do they compare? Quest Diagnostics Inc trades at $229.97 (market cap $25.48B), while GoPro Inc trades at $1.19 (market cap $243.50M). The key difference: Quest Diagnostics Inc is far larger — about 104.6× GoPro Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while GoPro Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and GoPro Inc for 45 Days on average.
| DGX | GPRO | |
|---|---|---|
Market Cap | $25.48B | $243.50M |
Volume | 941,866 | 11,527,160 |
Sector | Health | Technology |
52-Week High | $247.45 | $2.35 |
52-Week Low | $173.49 | $0.58 |
Typical Hold Time | 56 Days | 45 Days |
Enterprise Value | $31.23B | $302.28M |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.97, up 1.75% today, with a technical bias leaning bearish despite recent earnings beats. Revenue grew to $11.04B in 2025, with net income reaching $992M, though profit margins have moderated. Analyst consensus is a $250 price target with a mixed buy/hold sentiment. Recent news highlights growth in consumer testing and partnerships, alongside concerns over potential Medicare reimbursement cuts.
The outlook balances solid fundamentals and growth initiatives against regulatory risks. Upside potential exists from continued operational execution and new ventures like the Apple Health app integration, but investors face headwinds from reimbursement uncertainty and a high debt load. The stock's valuation appears reasonable relative to peers, supporting a cautious but opportunistic view.
GoPro (GPRO) trades at $1.19, down 2.46% on the day, as the stock consolidates following a volatile surge driven by merger news and influencer investment. The company shows concerning fundamentals with negative net income margins (-28.52%) and declining revenue trends, though valuation ratios appear attractive with P/E of 4.56 and P/S of 0.34. Recent developments include a planned $285 million merger with Starman Optical and significant stake acquisition by YouTube creator Markiplier, creating both opportunity and uncertainty.
The outlook remains highly speculative with the merger offering potential upside but facing shareholder litigation over valuation concerns. Investment opportunity exists if the Starman merger unlocks new AI/data center markets, but risks include persistent cash burn, competitive pressures from smartphones, and questions about the fairness of the $1.14 per share buyout price that could limit shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
